The progress of the research on cardio-vascular effects and acting mechanism of polydatin

Chinese Journal of Integrative Medicine

Volumn 18, Issue 9, 2012, Pages 714-719

  Liu, Long Tao ^a   Guo, Gang ^b   Wu, Min ^c   Zhang, Wen Gao ^d  

^a XIYUAN HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cardio vascular system; Mechanism study; Pharmacological action; Polydatin; Review

Indexed keywords

HERBACEOUS AGENT; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYDATIN; TOXIN; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR EFFECT; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN; LIPID BLOOD LEVEL; MEDICAL RESEARCH; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHIZOME; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR SMOOTH MUSCLE; VASODILATATION;

BIOMEDICAL RESEARCH; CARDIOVASCULAR SYSTEM; GLUCOSIDES; HUMANS; LIPID PEROXIDATION; MYOCYTES, CARDIAC; STILBENES; VASODILATION;

EID: 84867304413     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1060-8     Document Type: Review

References (33)

1. Kong XH, Zhou LZ. Study progress of giant knotweed rhizome. Guiding J Tradit Chin Med Pharm (Chin) 2009;15(5):107-110.
2. Gao SH, Yang SL, Fan GR. Study progress of polydatin. J Pharmaceutical Practice (Chin) 2005;23(5):145-147.
3. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007;2:133-138.
4. Zhang LP, Yang CY, Wang YP, Guan Y, Xu Y, Zhang Y. ATP-sensitive potassium channel and mitochondrial permeability transition pore involve in cardioprotection of polydatin. Chin J Pharm Toxicol (Chin) 2009;32:81-88.
5. Zhao J, Li HY, Wang ZH, Tong CQ. Effect of polydatin on ultrastructure of cardiac myocytes in rats with adriamycininduced myocardial damage. Acta Acad Med CPAPF (Chin) 2010;19:629-630,shift 634.
6. Zhang DQ, Sun LS, Xu JP. Effect of piceid on the dog with an acute myocardial infarction model. Herald Med (Chin) 2006;25:510-513.
7. Zhao Q, Huang HX, Jin CH. The regulation and its mechanism of polydatin on the β-adrenoreceptor in cardiac myocytes stimulated by lipopolysaccharide. Chin Pharm Bull (Chin) 2004;20:769-772.
8. Xue X, Jin CH, Li L, Xiang J. Influence of polydatin on myocardial function and ultrastructure of LPS infected rats. China Practical Med (Chin) 2008;3(33):3-4.
9. Gao JP, Chen CX, Gu WL, et al. Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models. Fitoterapia 2010;81:953-960.
10. Huang QB, Zhao KS, Huang XL. Effects of crytal No4 of polygonum cuspidatum, dopamine and 645-2 on hemorrhagic shock in rats. Chin J Microcirc (Chin) 1995;5(1): 7-9.
11. Liu J, Jin CH, Zhao KS. Effects of polydatin on ATP sensitive potassium channels of arteriolar smooth muscle cells. Chin J Microcirc (Chin) 1999;9(4):7-9.
12. Jin CH, Zhao KS. The regulat ion of polydat in on intracellular free calcium and membrane potential of human vascular smooth muscle cells. Chin J Pathophysiol (Chin) 1999;15:233-236.
13. Wang YG, Jin CH, Huang HX, Zhao Q, Wu SP. Effect of PD on the activity of protein kinase C of vascular smooth muscle cells. Chin Pharm Bull (Chin) 2005;2:461-464.
14. Wang YG, Jin CH, Huang HX, Wu PS. Effect of polydatin on the activity of protein kinase C of VSMC treated by LPS and sera of burned rats. J Fourth Military Med Univ (Chin) 2006;27:1960-1962.
15. Wang Y, Xue J, Sun XD, Yuan BX, Deng XL, Yu XJ. Study on decreasing effects of polydatin on blood viscosity in the rat model of acute blood stasis. China Pharm 2004;15:275-277.
16. Chen P, Yang LC, Lei WY, Shen ZQ, Wang DH. Investigation on antithrombotic effects of polydatin. J Kunming Med Coll (Chin) 2006;27(1):10-12.
17. Chen P, Hu XL, Lei WY, Shen ZQ. Effects of polydatin on thrombosis and interactions of platelets to neutrophils. J Yunnan Univ (Natural Sci, Chin) 2006;28(4):364-368.
18. Chen P, Yang LC, Hu XL, Lei WY, Shen ZQ. Investigation of polydatin on antithrombotic effects and plasma levels of TXB2 and 6-keto-PGF1α. Nat Prod Res Dev (Chin) 2006;18:398-400, shift 404.
19. Zhu LX, Jin ZY. Effect of polydatin on metabolism of blood lipid of hyperlipidemia rats and its antioxidation. Chin Tradit Patent Med (Chin) 2006;28:260-261.
20. Du J, Sun LN, Xing WW, et al. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 2009;16:652-658.
21. Xing WW, Wu JZ, Jia M, Du J, Zhang H, Qin LP. Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits. Biomed Pharmacother 2009; 63:457-462.
22. Qin J, Chen YZ, Zhou QX, Shi RF, Jiang QS, Lou Q. Effect of polydatin on endothelial function in aorta vascular strips of healthy rabbits treated with ADMA. Chin Tradit Herbal Drugs (Chin) 2004;35:535-538.
23. Zhu LX, Jin ZY. Effects of piceid on blood lipid metabolism, nitric oxide and nitricoxide synthase in experimental hyperlipidemia rats. Pharm Clin Chin Materia Med (Chin) 2005;21(3):16-18.
24. Xu FQ, Xu H, Liu JG, Chen KJ. Effects of Xiongshao Capsule on the proliferation of vascular smooth muscle cells in rabbits with atherosclerosis. Chin J Integr Tradit West Med (Chin) 2008;28:912-916.
25. Zhou XM, Zhou DX, Liu Y, Hong L. Progress research on regulating vascular smooth muscle cell proliferation by TCM intervention. Chin J Modern Drug Application (Chin) 2010;4:224-225.
26. Zhou ZM, Feng YB, Zhou YJ. Effect of resveratrol on the proliferation of cultured vascular smooth muscle cells. Chin J Geriatric Cardiovasc Cerebrovasc Dis (Chin) 2004;6:335-337.
27. Wang QQ, Jiao JJ, Li WH, Qu Q. Effects of resveratrol on the proliferation and CaN of vascular smooth muscle cell induced by angiotensinII. Chin J of Appl Physiol (Chin) 2009; 25:334-337.
28. Poussier B, Cordova AC, Becquemin JP, Sumpio BE. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vascular Surg 2005;42:1190-1197.
29. Konishi A, Aigawa T, Mohan A, Korshunov VA, Berk BC. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem 2004;279:28766-28770.
30. Su D, Zhang BL, Huan ML, Huang QJ, Zhu CL, Zhou SY. Comparison of resveratrol and polydatin on anti-oxidative activities. China Pharmacist (Chin) 2010;13:471-473.
31. Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007;75:468-477.
32. Xiao MJ, Chen WH, Wu W, Guo W, Zhao KS, Zhao M. Polydatin inhibits lipid peroxidation induced by ox-LDL and down-regulates CD36 expression in macrophages. Chin J Pathophysiol (Chin) 2010;26:1280-1284.
33. Liu LT, Wu Min, Zhang WG, Zheng GJ, Yin JH, Liu MX, et al. Intervention study of polydatin on plaque stability of carotid ahterosclerosis. Beijing J Tradit Chin Med (Chin) 2009;2:172-175.